Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

Overview of attention for article published in Oncologist, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs: 1 blog
twitter: 4 X users

facebook: 1 Facebook page

Readers on

mendeley: 76 Mendeley

So far, Altmetric has seen 1 blog post.

Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.

Clinowl, 08 Feb 2021

Despite the initial optimism for using immune checkpoint inhibition in the treatment of multiple myeloma, subsequent clinical…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.